Complete Surgical Excision Is the Most Effective Treatment for BI-ALCL
An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.
An MD Anderson-led study finds surgery improves survival, reduces recurrence in BI-ALCL.
RVL Pharmaceuticals reported 22% revenue growth for Upneeq in Q3 2025 and announced leadership changes to support continued expansion of the product.